Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating tumour DNA alterations as biomarkers for head and neck cancer: a systematic review.

Acta oncologica (Stockholm, Sweden) - 1 Jul 2020

Pall Amalie Hartvig, Jakobsen Kathrine Kronberg, Grønhøj Christian, von Buchwald Christian

Abstract excerpt

Background: Head and neck squamous cell carcinoma (HNSCC) is a significant global burden. The development of a diagnostic or recurrence monitoring test could evolve from the exploitation of molecular markers such as tumour-specific DNA alterations in plasma. The aim of this study was to report specific genetic alterations of DNA in plasma from HNSCC patients, report the diagnostic accuracy, and discuss potentials...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclin-Dependent Kinase Inhibitor p15
Share to Cyclin-Dependent Kinase Inhibitor p16

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Death-Associated Protein Kinases

Share to DNA, Neoplasm

Share to Head and Neck Neoplasms

Share to Neoplasm Recurrence, Local

Share to Squamous Cell Carcinoma of Head and Neck

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 32223478
DOI: 10.1080/0284186X.2020.1742930

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating tumour DNA alterations as biomarkers for head and neck cancer: a systematic review.PMID 32223478Read ↗

Next-Generation Sequencing of Plasma Cell-Free DNA for Treatment Monitoring in Advanced Head and Neck Cancer Patients.Semantic proximity Read ↗

Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC).Semantic proximity Read ↗

The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma.Semantic proximity Read ↗

Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinomaSemantic proximity Read ↗

A comparison between mutational profiles in tumour tissue DNA and circulating tumour DNA in head and neck squamous cell carcinoma - A systematic review.Semantic proximity Read ↗

Does circulating tumor DNA apply as a reliable biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma?Semantic proximity Read ↗

Mutated TP53 in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Carcinoma PatientsSemantic proximity Read ↗

Circulating tumor DNA detection in head and neck cancer: evaluation of two different detection approachesSemantic proximity Read ↗

Comprehensive multiparameter genetic analysis improves circulating tumor DNA detection in head and neck cancer patientsSemantic proximity Read ↗

Personalized circulating tumor DNA dynamics predict survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancerSemantic proximity Read ↗

Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.